Cargando…
The Retina in Patients With Triple A Syndrome: A Window Into Neurodegeneration?
OBJECTIVE: Experimental evidence suggests that the clinical manifestations of Triple A syndrome result from oxidative stress. Several conditions caused by oxidative stress display retinal involvement. Our objective was to assess the retina and optic nerve involvement in children with Triple A syndro...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8633871/ https://www.ncbi.nlm.nih.gov/pubmed/34867779 http://dx.doi.org/10.3389/fendo.2021.729056 |
_version_ | 1784608016792813568 |
---|---|
author | Ulgiati, Fiorenza Lhoir, Sophie Balikova, Irina Tenoutasse, Sylvie Boros, Emese Vilain, Catheline Heinrichs, Claudine Brachet, Cécile |
author_facet | Ulgiati, Fiorenza Lhoir, Sophie Balikova, Irina Tenoutasse, Sylvie Boros, Emese Vilain, Catheline Heinrichs, Claudine Brachet, Cécile |
author_sort | Ulgiati, Fiorenza |
collection | PubMed |
description | OBJECTIVE: Experimental evidence suggests that the clinical manifestations of Triple A syndrome result from oxidative stress. Several conditions caused by oxidative stress display retinal involvement. Our objective was to assess the retina and optic nerve involvement in children with Triple A syndrome. METHODS: Eleven patients with genetically proven Triple A syndrome followed-up in our centre were approached for study participation. The main outcome was the measurement of the thicknesses of the different retinal layers by Optical Coherence Tomography (OCT). RESULTS: 9 patients with triple A syndrome had OCT measurements. 7 patients were children and 2 were adults; 4 were females and 5 were males. The 7 paediatric patients had at least two OCT measured at a mean interval of 7.9 months after the first one. The average Retinal Nerve Fibre Layer thickness was 74 ± 10 µm in patients compared to the paediatric reference range of 100 ± 2 µm (p<0.05). CONCLUSIONS AND RELEVANCE: This is the first study to document retinal layer thicknesses in a series of patients with Triple A syndrome. Nearly all retinal thickness and peripapillary RNFL measurements were very significantly inferior to the reference range in Triple A patients, whatever their age. RNFL thinning was more marked at the temporal part of the optic nerve. OCT being non-invasive, it represents a promising tool to assess the severity of neurodegeneration in patients with Triple A syndrome. |
format | Online Article Text |
id | pubmed-8633871 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-86338712021-12-02 The Retina in Patients With Triple A Syndrome: A Window Into Neurodegeneration? Ulgiati, Fiorenza Lhoir, Sophie Balikova, Irina Tenoutasse, Sylvie Boros, Emese Vilain, Catheline Heinrichs, Claudine Brachet, Cécile Front Endocrinol (Lausanne) Endocrinology OBJECTIVE: Experimental evidence suggests that the clinical manifestations of Triple A syndrome result from oxidative stress. Several conditions caused by oxidative stress display retinal involvement. Our objective was to assess the retina and optic nerve involvement in children with Triple A syndrome. METHODS: Eleven patients with genetically proven Triple A syndrome followed-up in our centre were approached for study participation. The main outcome was the measurement of the thicknesses of the different retinal layers by Optical Coherence Tomography (OCT). RESULTS: 9 patients with triple A syndrome had OCT measurements. 7 patients were children and 2 were adults; 4 were females and 5 were males. The 7 paediatric patients had at least two OCT measured at a mean interval of 7.9 months after the first one. The average Retinal Nerve Fibre Layer thickness was 74 ± 10 µm in patients compared to the paediatric reference range of 100 ± 2 µm (p<0.05). CONCLUSIONS AND RELEVANCE: This is the first study to document retinal layer thicknesses in a series of patients with Triple A syndrome. Nearly all retinal thickness and peripapillary RNFL measurements were very significantly inferior to the reference range in Triple A patients, whatever their age. RNFL thinning was more marked at the temporal part of the optic nerve. OCT being non-invasive, it represents a promising tool to assess the severity of neurodegeneration in patients with Triple A syndrome. Frontiers Media S.A. 2021-11-12 /pmc/articles/PMC8633871/ /pubmed/34867779 http://dx.doi.org/10.3389/fendo.2021.729056 Text en Copyright © 2021 Ulgiati, Lhoir, Balikova, Tenoutasse, Boros, Vilain, Heinrichs and Brachet https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Endocrinology Ulgiati, Fiorenza Lhoir, Sophie Balikova, Irina Tenoutasse, Sylvie Boros, Emese Vilain, Catheline Heinrichs, Claudine Brachet, Cécile The Retina in Patients With Triple A Syndrome: A Window Into Neurodegeneration? |
title | The Retina in Patients With Triple A Syndrome: A Window Into Neurodegeneration? |
title_full | The Retina in Patients With Triple A Syndrome: A Window Into Neurodegeneration? |
title_fullStr | The Retina in Patients With Triple A Syndrome: A Window Into Neurodegeneration? |
title_full_unstemmed | The Retina in Patients With Triple A Syndrome: A Window Into Neurodegeneration? |
title_short | The Retina in Patients With Triple A Syndrome: A Window Into Neurodegeneration? |
title_sort | retina in patients with triple a syndrome: a window into neurodegeneration? |
topic | Endocrinology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8633871/ https://www.ncbi.nlm.nih.gov/pubmed/34867779 http://dx.doi.org/10.3389/fendo.2021.729056 |
work_keys_str_mv | AT ulgiatifiorenza theretinainpatientswithtripleasyndromeawindowintoneurodegeneration AT lhoirsophie theretinainpatientswithtripleasyndromeawindowintoneurodegeneration AT balikovairina theretinainpatientswithtripleasyndromeawindowintoneurodegeneration AT tenoutassesylvie theretinainpatientswithtripleasyndromeawindowintoneurodegeneration AT borosemese theretinainpatientswithtripleasyndromeawindowintoneurodegeneration AT vilaincatheline theretinainpatientswithtripleasyndromeawindowintoneurodegeneration AT heinrichsclaudine theretinainpatientswithtripleasyndromeawindowintoneurodegeneration AT brachetcecile theretinainpatientswithtripleasyndromeawindowintoneurodegeneration AT ulgiatifiorenza retinainpatientswithtripleasyndromeawindowintoneurodegeneration AT lhoirsophie retinainpatientswithtripleasyndromeawindowintoneurodegeneration AT balikovairina retinainpatientswithtripleasyndromeawindowintoneurodegeneration AT tenoutassesylvie retinainpatientswithtripleasyndromeawindowintoneurodegeneration AT borosemese retinainpatientswithtripleasyndromeawindowintoneurodegeneration AT vilaincatheline retinainpatientswithtripleasyndromeawindowintoneurodegeneration AT heinrichsclaudine retinainpatientswithtripleasyndromeawindowintoneurodegeneration AT brachetcecile retinainpatientswithtripleasyndromeawindowintoneurodegeneration |